Postpartum depression affects approximately 15% of mothers. Unfortunately, treatment options for postpartum depression are limited. Pharmacological antidepressants such as fluoxetine (FLX) can be controversial due to inconclusive evidence of efficacy during the postpartum and concerns of neonatal exposure to antidepressants. Alternatively, non-pharmacological antidepressants such as exercise may be less controversial but its efficacy in postpartum depression is unclear. To investigate this, we treated rat dams daily with high levels of corticosterone (CORT; 40 mg/kg), to induce a depressive-like phenotype, or oil (vehicle for CORT) during the postpartum period. Within the oil and CORT conditions, four additional antidepressant conditions were created: 1. FLX (10 mg/kg) þ exercise (voluntary access to running wheel); 2. FLX þ no exercise; 3. Saline (vehicle for FLX) þ exercise; 4. Saline þ No exercise. We examined maternal care, depressive-like and anxiety-like behavior, stress reactivity, and hippocampal neurogenesis and dams were categorized as "high running" or "low running." FLX treatment, alone or with high running, prevented CORT-induced disruptions in maternal care. As expected, CORT increased depressivelike behavior but exercise, regardless of running amount, reduced depressive-like behavior. Intriguingly, FLX, but not CORT, increased anxiety-like behavior, which was not mitigated by concurrent exercise. FLX treatment slightly but significantly facilitated serum CORT recovery after forced swim stress. CORT and FLX alone reduced neurogenesis, while exercise coupled with FLX increased density of doublecortinexpressing cells. High running increased density of doublecortin-expressing cells (immature neurons) in comparison to controls. Collectively, these findings indicate that FLX and exercise reverse different endophenotypes of depression in dams, which has translational implications for surveying treatment options of postpartum depression.
Introduction
Physical exercise is beneficial for mood (Rethorst and Trivedi, 2013) , but its ability to benefit mood during motherhood is unclear. Indeed, exercise increases neurotrophic factors, neuroplasticity, and hippocampal neurogenesis, which may underlie the numerous benefits of exercise on mental well-being (Voss et al., 2013) . However, hippocampal volume, trophic factors, and neurogenesis are reduced during pregnancy and lactation (Leuner et al., 2007; Pawluski and Galea, 2007; Hoekzema et al., 2017) . Therefore, it is possible that the capacity for exercise to benefit mood and neuroplasticity is compromised during motherhood. It is imperative to evaluate the efficacy of antidepressant interventions, including exercise, in treating depression specifically in mothers. Approximately 15% of mothers suffer from postpartum depression (PPD; Wisner et al., 2013) with 75% of women with maternal depression experiencing their first ever episode of depression (Fisher et al., 2016) . Treatment options for PPD are currently limited, and addressing this limitation is necessary for the health of the mother and child. To this end, the following study compares the antidepressant effects of exercise alone or in conjunction with pharmacological antidepressant fluoxetine (FLX) in a rat model of PPD.
Systematic reviews evaluating efficacy of postpartum use of selective serotonin reuptake inhibitors (SSRIs) suggest that these drugs are no more effective than placebo in mothers by 3e6 months postpartum (Yonkers et al., 2008; De Crescenzo et al., 2014) . Other antidepressants like ketamine (Xu et al., 2017) may have limited preventative benefits in the postpartum. Nonetheless, approximately 6% of mothers use antidepressants after childbirth (Smolina et al., 2015) . SSRIs are problematic during pregnancy and the postpartum because they can cross the placenta and remain active in breast milk, potentially affecting infant development (Weissman et al., 2004) . Whether developmental SSRI exposure outweighs the adverse effects of maternal depression on child development remains unclear. For this reason, some mothers hesitate to seek antidepressant treatment for PPD, and some women preemptively disengage from prescription antidepressant use during pregnancy (Prady et al., 2016) , risking potential relapse of depression. Alternatively, women may be more compliant in using non-pharmacological antidepressants such as exercise due to fewer side effects and concerns for infant outcome. However, systematic reviews of clinical studies investigating the effects of exercise during pregnancy have been inconclusive regarding whether prenatal exercise or postnatal exercise prevents PPD (Dennis, 2004; Ersek and Brunner Huber, 2009; Daley et al., 2015; Hinman et al., 2015) . Both exercise and FLX are well-validated antidepressants outside of pregnancy and postpartum periods but may have altered efficacy during this time. Thus, this study aims to comprehensively evaluate how the combination of both treatments in comparison to either exercise or FLX alone affects maternal outcome in terms of maternal care, hypothalamic-pituitary-adrenal (HPA) axis activity, affective behavior, and hippocampal neurogenesis in a rat model of PPD.
Our laboratory has developed a model of PPD in which a high dose of corticosterone (CORT; primary glucocorticoid in rats) is administered daily during the postpartum period, modelling index depression episode in the postpartum, which accounts for 40% of cases of maternal depression (Fisher et al., 2016) . This CORTinduced model of depression capitalizes on the well-established relationship between stress and depression (Angst et al., 2002) including PPD (Seth et al., 2016) . Postpartum CORT treatment induces a PPD-like phenotype by reducing time spent with the offspring, increasing depressive-like behavior, and reducing hippocampal neurogenesis and plasticity (Brummelte et al., 2006; Brummelte and Galea, 2010; Workman et al., 2013) . We recently reported that maternal postpartum FLX treatment prevented CORTinduced disruptions in maternal care early in the postpartum but was unable to rescue CORT-induced depressive-like behavior, flattening of HPA axis activity, or reductions in hippocampal neurogenesis in dams . To expand upon these findings, we sought to determine whether exercise (voluntary running) would prevent CORT-induced depressive-like endophenotypes in dams or potentially boost the efficacy of FLX in the postpartum. We hypothesized that exercise alone, or in conjunction with FLX, would alleviate CORT-induced disruptions in maternal care, depressive-like behavior, HPA axis activity, and hippocampal neurogenesis in dams.
Materials and methods

Animals
Sixty adult female Sprague-Dawley rats (~2 months old) and fifteen adult male Sprague-Dawley rats (2 months old, Charles River, QC) were given rat chow (Jamieson's Pet Food Distributors Ltd, Delta, BC, Canada) and tap water ad libitum. Rats were individually housed in transparent polyurethane bins (27 Â 25 Â 20 cm) with aspen chip bedding and maintained in a 12 h: 12 h light/dark cycle (lights on at 7:00 a.m.). All protocols were in accordance with ethical guidelines set by Canadian Council on Animal Care and were approved by the University of British Columbia Animal Care Committee. The timeline of the experiment is depicted in Fig. 1. 
Exercise treatment
Upon arrival in the facility, female rats were randomly assigned to either standard housing with no running wheel ("no exercise; " n ¼ 30) or with access to running wheels ("exercise; " n ¼ 30; Med Associates Inc., VT, USA) and groups were housed in separate colony rooms. Running wheel activity was recorded daily and in total dams were given access to the running wheel for 8 weeks (±4 days, due to the variability in length of time to conceive). Dams had voluntary access to running wheel during pre-conception, pregnancy, and postpartum periods in order to: 1) prevent additional postpartum stress (besides CORT treatment) of introducing running wheel during the postpartum, 2) prevent any stress associated with removal of the wheel at any point, and 3) allow sufficient acclimation to engage in running wheel activity, which can be sensitive to ovarian hormone changes (Park et al., 2016) .
Breeding procedures
Breeding was conducted as previously described . During pregnancy, dams were left undisturbed besides weekly weighing and cage-changing. One day after birth (birth day ¼ postpartum day 0), all litters were culled to 4 males and 4 females.
Drug preparation and treatment
Dams were randomly assigned to one of four treatment groups within both exercise and non-exercise conditions: 1) CORT/FLX (exercise, n ¼ 8; non-exercise, n ¼ 9); 2) CORT/saline (exercise, n ¼ 8; non-exercise, n ¼ 8); 3) oil/FLX (exercise, n ¼ 7; nonexercise, n ¼ 7); 4) oil/saline (exercise, n ¼ 7; non-exercise, n ¼ 6). Beginning on postpartum day 2, dams received two daily injections of either CORT (40 mg/kg, s.c.) or sesame oil (1 ml/kg and 10% EtOH, s.c.) and FLX (10 mg/kg, i.p.) or saline (1 ml/kg and 10% DMSO) for 24 consecutive days. Dams received both injections in succession between 8:30 a.m. and 10:30 a.m. CORT (Sigma-Aldrich, St. Louis, MO, USA) and FLX (Sequoia Research Products, Pangbourne, UK) were prepared as previously described . The CORT dose reliably induces a depressive-like phenotype in dams and impairs maternal care (Brummelte et al., 2006; Brummelte and Galea, 2010; Workman et al., 2013) . The FLX dose increased brain derived neurotrophic factor, and hippocampal cell proliferation after 21 days of injections in both sexes (Hodes et al., 2010) .
Maternal behavior
Maternal observations were conducted twice per day from postpartum day ( PD) 2e8. Observations occurred at least 2 h after injections or after previous observation. Each observation lasted for 10 min and duration of the following behaviors were scored: nursing (including arched back nursing, blanket nursing, and passive nursing), licking, nursing and licking, self-grooming, and off nest. Time spent running during maternal observation was also quantified in the exercise groups. Data was summated across all observations.
Forced swim test (FST)
Dams were tested in the FST on postpartum day 22 (FST1) and 23 (FST2) to assess antidepressant efficacy as previously described . Behavioral testing began approximately at 12:30 p.m. Briefly, dams were placed into clean water for 15 min on postpartum day 22 and for 5 min on postpartum day 23. Sessions were scored blinded for percent time spent immobile during the first minute and across the total 5 minutes using BEST Collection Software (Educational Consulting, Inc., Hobe Sound, FL, USA). We scored the first minute as well as the total of 5 minutes due to the fact that minute by minute changes are seen in the FST with greater differences in immobility observed early in the test session (des Portes et al., 1998; Mezadri et al., 2011) ; additionally, because blood was collected after FST1, we reasoned that this may affect immobility in all animals (see below).
Blood collection and serum CORT assay
Immediately after FST1, a blood sample was collected via the tail vein to measure stress-induced levels of CORT. During recovery, rats were returned to home cages, and another blood sample was collected 2 h later. Rats in the exercise condition were not allowed access to running wheel during these 2 h to prevent exerciseinduced elevations in CORT. Blood samples were stored overnight at 4 C, centrifuged at 10,000 g for 15 min and serum collected and stored at À20 C until radioimmunoassay. Total CORT (bound and free) was measured in duplicate using the ImmuChem Double Antibody 125I radioimmunoassay Kit (MP Biomedicals, Solon, OH, USA). The antiserum cross-reacts 0.05% with cortisol, and does not cross-react with dexamethasone (<0.01%). Intra-assay coefficient of variation was 5%.
Novelty suppressed feeding
Rats were tested for anxiety-like behavior in the novelty suppressed feeding paradigm as previously described (Mahmoud et al., 2016) 24 h after FST2. In this test, rats must resolve an anxiogenic conflict of entering the center of arena to access a Froot Loop after 16 h of food deprivation (Bessa et al., 2009) . Behavioral testing began approximately at 11:00 a.m. Latency to feed was recorded as an index of anxiety-like behavior. The trial was terminated either after the rat began to eat or after 10 min, whichever came first. Home cage food consumption was measured for 1 h after the test.
Tissue collection and immunohistochemistry
Twenty-four h after novelty suppressed feeding test, rats were given an overdose of sodium pentobarbital and perfused with 60 ml cold 0.9% saline followed by 120 ml cold 4% paraformaldehyde. Adrenal glands were collected and weighed. Brains were extracted, postfixed overnight at 4 C, and transferred to 30% sucrose in phosphate buffer at 4 C. Brains were rapidly frozen with dry ice and sectioned coronally at 40 mm using a freezing microtome (Leica, Richmond Hill, ON, Canada). Sections were stored in series of 10 in antifreeze (ethylene glycol/glycerol; Sigma) at À20 C until processing.
Immunohistochemistry for doublecortin (DCX), an endogenous marker of immature neurons (Brown et al., 2003) , was conducted as described . Briefly, between PBS rinses, sections were treated with 0.3% hydrogen peroxide (30 min) and incubated at 4 C for 24 h in primary antibody solution (1:1000, goat anti-DCX; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Sections were rinsed and incubated in a secondary antibody solution (1:500, rabbit anti-goat; Vector Laboratories, Burlington, ON, Canada) at 4 C for 24 h. Then, rinsed sections were incubated in ABC complex (ABC Elite Kit; 1:1000; Vector) for 4 h. Sections were developed using diaminobenzidine in the presence of nickel (DAB Peroxidase Substrate Kit, Vector), and counterstained with cresyl violet.
Microscopy
DCX-expressing cells were quantified in 3 dorsal sections (À2.76 mm to À4.68 mm below bregma) and 3 ventral sections (À5.52 mm to À6.60 mm below bregma) using the 40Â objective using an Olympus CÂ22LED brightfield microscope. Areas of these sections were quantified using ImageJ (NIH, Bethesda, MD, USA) and used for density calculations (number of cells per mm 2 ).
Additionally, 50 DCX-positive cells in dorsal (n ¼ 25) and ventral (n ¼ 25) dentate gyrus were randomly selected and classified as either proliferative, intermediate, or post-mitotic as previously described .
Data analyses
Litter characteristics were analyzed using independent t-tests. Data from maternal observations, FST, and novelty suppressed feeding test were analyzed using ANOVA with exercise, CORT, and FLX as between-subjects factors. CORT concentrations after the FST were analyzed using repeated measures ANOVA with time as the within-subjects factor. The density of DCX-expressing cells was analyzed using repeated measures ANOVA with region (dorsal, ventral) as the within-subjects factor. Post hoc comparisons used Newman-Keuls. A priori comparisons were subjected to Bonferroni corrections. Post-hoc analyses of running data categorized dams as either high or low runners using a median split. All data were analyzed using Statistica software (v. 9, StatSoft, Inc., Tulsa, OK, USA). All effects were considered statistically significant if p 0.05. 
Results
Running was reduced during the final week of gestation and with postpartum FLX
Before drug treatment, dams maintained consistent levels of running from pre-conception through the second week of gestation (p's > 0.45). Dams ran less during the third week of gestation in comparison to previous time points (p's < 0.001; main effect of week). Due to the high variability in running we categorized dams as either high or low running using a median split on amount of running before drug treatment began ( Fig. 2A) , and subsequent post-hoc analyses were conducted with high and low running as a variable. However, because this resulted in an unbalanced design due to skewed sample sizes within these groups, data are presented as exploratory analyses.
Running wheel activity increased from the second to the third week of the postpartum period in saline-treated dams (p < 0.001). However, this increase was not observed in FLX-treated dams Neither postpartum CORT nor FLX treatment interacted with Fig. 2 . A) Individual running data based on average revolutions per day before drug treatment began. Individual dams were categorized as "high running" or "low running" based on a median split (n ¼ 15/group). B) During pre-conception and gestation periods, high running dams consistently ran significantly more than low running dams. Regardless of high or low running, dams voluntarily ran at similar levels during pre-conception and first two weeks of gestation. Dams ran less during the third and final week of gestation in comparison to earlier periods. After parturition and regardless of drug treatment, all dams ran at comparable levels during the first two postpartum weeks. During the third week of the postpartum, FLX reduced running in comparison to saline in high runners only. *p < 0.05; FLX: fluoxetine; HR: high running; LR: low running. FLX; p ¼ 0.009). There were no other significant main or interaction effects of maternal exercise, CORT, and FLX treatment on time spent self-grooming (all p's > 0.06). These data are summarized in Table 2 .
Exercise reduced immobility while postpartum CORT or FLX increased immobility in the forced swim test
Exercise decreased time spent immobile in comparison to no Table 2 Mean percent time spent licking, nursing þ licking, and self-grooming ± SEM. Maternal exercise, CORT, and FLX treatment did not significantly affect time spent licking. Nonexercising/CORT-treated dams spent more time nursing þ licking in comparison to non-exercising/oil-treated dams. Postpartum FLX treatment reduced time spent selfgrooming in comparison to saline. *p < 0.05; CORT: Corticosterone; FLX: Fluoxetine.
Mean % time licking ± SEM Mean % time nursing þ licking ± SEM Mean % time self-grooming ± SEM Exercise Oil/Saline 0.4 ± 0.1 10.2 ± 2.1 9.9 ± 1.1 Oil/FLX 0.3 ± 0.2 10.5 ± 1.9 7.9 ± 1.3 * CORT/Saline 0.6 ± 0.2 8.7 ± 2.1 10.7 ± 1.5 CORT/FLX 0.2 ± 0.1 7.7 ± 1.4 6.8 ± 1.2* No Exercise
Oil/Saline 0.3 ± 0.1 7.1 ± 1.0 12.8 ± 1.8 Oil/FLX 0.2 ± 0.1 8.8 ± 1.3 7.5 ± 1.8* CORT/Saline 0.8 ± 0.3 13.4 ± 3.0* 12.8 ± 2.0 CORT/FLX 0.5 ± 0.2 11.2 ± 2.9* 11.2 ± 2.0* Fig. 4 . A) Postpartum CORT and postpartum FLX independently increased time spent immobile in FST2 in comparison to oil and saline, respectively. Exercise reduced time spent immobile in comparison to no exercise. B) Immediately after FST1, all dams reached similar levels of stress-induced serum CORT regardless of CORT, FLX, or exercise. After 2 h, CORTtreated dams maintained elevated serum CORT levels in comparison to oil-treated dams. There was a slight but significant effect of FLX to reduce serum CORT levels in comparison to saline among CORT-treated dams. C) FLX increased latency to feed in comparison to saline in novelty suppressed test. D) FLX increased latency to feed in comparison to saline in high running dams but not low or no running dams. Fig. 4A ]. There were no significant effects of running amount (p's > 0.27). We used body mass as a covariate to account for its influence on immobility, and it did not significantly alter our results with main effects of exercise, CORT and FLX still evident. Across the 5 min session, the main effect of exercise to reduce time spent immobile persisted (p ¼ 0.03; Table 3 ). However, there were no longer any significant effects of either CORT or FLX or any significant interactions (all p's > 0.16).
3.4. Maternal postpartum CORT impaired, while FLX treatment facilitated, CORT recovery after stress in the CORT-treated dams Immediately after FST1, both oil-treated and CORT-treated dams showed similar levels of serum CORT (p ¼ 0.10). However, 2 h after FST1, CORT-treated dams maintained elevated serum CORT levels in comparison to oil-treated dams [p < 0.001; interaction between time and CORT; F (1, 43) ¼ 6.831, p ¼ 0.02; Fig. 4B] . A priori comparisons revealed that 2 h after FST1, serum CORT levels were significantly lower in oil/saline, oil/FLX, and CORT/FLX dams (p's < 0.001) but not CORT/saline dams [p ¼ 0.13; interaction between time, CORT, and FLX; F (1, 42) ¼ 1.08; p ¼ 0.07; Fig. 4B ]. No other significant main or interacting effects were present (all p's > 0.11). There were no significant effects of running amount (p's > 0.12).
3.5. Postpartum FLX treatment increased anxiety-like behavior in the novelty suppressed feeding test FLX treatment increased latency to feed in novelty suppressed feeding in comparison to saline (main effect of FLX; p ¼ 0.047; Fig. 4C ). No other main or interaction effects were present (p's > 0.29). FLX increased latency to feed only among high running dams (p < 0.001) but not low (p ¼ 0.9) or no running dams [p ¼ 0.14; interaction between running amount and FLX; F (2, 48) ¼ 4.4; p ¼ 0.018; Fig. 4D ].
FLX-treated dams and CORT-treated dams consumed significantly less food 1 h after testing than saline-treated dams (main effect of FLX; p ¼ 0.01; main effect of CORT; p ¼ 0.004; Table 4 ). No other main or interaction effects were present (p's > 0.521). We used food consumption as a covariate for the novelty suppressed feeding data: there was no significant effect of the covariate (p ¼ 0.13) although it did render the effect of postpartum FLX treatment to be a trend (p ¼ 0.07).
3.6. Postpartum CORT reduced density of DCX-expressing cells whereas exercise and FLX together increased DCX in exercising dams; high running increased density of DCX-expressing cells in ventral hippocampus FLX increased density of DCX-expressing cells in exercising dams (compared to all other groups p's < 0.03) but decreased the density of DCX-expressing cells in non-exercising dams [p ¼ 0.007; exercise/FLX interaction; F (1, 52) ¼ 3.91; p ¼ 0.05; Fig. 5B ].
Exercise increased density of DCX-expressing cells in ventral (p < 0.001) but not dorsal dentate gyrus [p ¼ 0.14; region/exercise interaction; F (1, 52) ¼ 10.97; p ¼ 0.002; Fig. 5C ]. In ventral hippocampus, high running increased density of DCX-expressing cells compared to low (p < 0.001) or no running dams [p < 0.001; region/ running amount interaction; F (2, 48) ¼ 6.7; p ¼ 0.003; Fig. 5D ]. There were no significant differences in dorsal hippocampus (p's > 0.42).
Postpartum CORT decreased density of DCX-expressing cells in both dorsal (p < 0.001; Fig. 5E ) and ventral regions (p < 0.001; 3.9. Exercise reduced body mass during pregnancy; postpartum CORT reduced body mass by the end of the postpartum During pregnancy, all dams gained body mass (main effect of week; p ¼ 0.001) but exercise dams maintained a lower body mass than non-exercising dams (main effect of exercise; p ¼ 0.001; Table 3 ). As expected, maternal postpartum CORT reduced body mass of the dams in comparison to oil treatment (main effect of CORT; p < 0.001) but no other significant main or interaction effects were present (p's > 0.08).
Exercise did not affect litter parameters
Exercise had no significant effects on litter outcome [number of pups: p ¼ 0.36, litter body mass: p ¼ 0.16; litter sex ratio: p ¼ 0.45; Table 5 ]. There were no significant effects of running amount (p's > 0.35). 3.11. Exercise increased relative adrenal mass among oil/saline dams whereas FLX increased relative adrenal mass among nonexercising/oil dams Exercise increased relative adrenal mass in comparison to no exercise among oil/saline treated dams (p < 0.001) but not under any drug/hormone condition (p's > 0.68). Postpartum CORT reduced relative adrenal mass in comparison to oil regardless of exercise or FLX exposure (p's < 0.001). Under no exercise/oil conditions, FLX treatment increased relative adrenal mass in comparison to saline [p < 0.001; exercise, CORT, and FLX interaction; F (1, 50) ¼ 5.33; p ¼ 0.03].
Discussion
Few studies have investigated antidepressant efficacy in models of maternal depression, raising concerns regarding how to best treat PPD. Postpartum CORT reduced maternal care, increased depressive-like behavior, and reduced hippocampal neurogenesis, which is consistent with our prior results (Brummelte and Galea, 2010; Workman et al., 2016) . Intriguingly, voluntary exercise, but not FLX treatment, prevented CORT-induced depressive-like behavior and increased hippocampal neurogenesis. Additionally, FLX alone or the combination of high maternal exercise and postpartum FLX prevented CORT-induced reductions in maternal care. These results suggest that voluntary exercise, particularly with greater running amount, could be used as an effective treatment or adjunct treatment with FLX. One caveat is that FLX and high running also increased anxiety-like behavior which is often an initial side effect of FLX in patients (Messiha, 1993) . Collectively, these data suggest that exercise and FLX differentially impact CORT-induced endophenotypes of PPD (summarized in Table 6 ).
Postpartum FLX prevented CORT-induced disruptions in maternal care under sedentary and high running conditions; exercise did not impact litter parameters
We replicated previous findings that FLX treatment prevented CORT-induced reductions in maternal care in sedentary conditions . Interestingly, voluntary exercise itself was not sufficient to prevent CORT-induced reductions in maternal care, but rather the combination of high levels of voluntary running and postpartum FLX treatment were sufficient. Possible mechanisms underlying this observation are changes in hippocampal plasticity (discussed below) or alterations in serotonin transmission. High intensity aerobic exercise but not low or moderate levels increased serum serotonin levels in humans (both men and women; Zimmer et al., 2016) , and running is associated with increased brain serotonin in rodents (only males studied; Liu et al., 2017; Wang et al., 2013) . Serotonin transmission can in part regulate maternal behavior (Lerch-Haner et al., 2008) . Therefore, modification of maternal behavior by FLX under sedentary and high running conditions may be indicative of altered serotonergic tone. Cortical and hippocampal serotonin levels are naturally lower during pregnancy and postpartum (Desan et al., 1988 ) and exposure to glucocorticoids may exacerbate this reduction (Bambico et al., 2009) . Although the exact role of serotonin in maternal behavior is still under investigation, serotonin turnover is higher in the preoptic area of the hypothalamus, a region crucial for expression of maternal behavior (Lonstein et al., 2003) . Therefore, under high CORT conditions, it is possible that FLX preserves maternal behavior by increasing synaptic serotonin levels and that high running further bolsters serotonin transmission and subsequently the efficacy of FLX. Further research could explore the interaction between stress and serotonin in the postpartum brain, particularly the hippocampus and hypothalamus, to clarify the neural mechanism underlying CORT-induced perturbations to maternal behavior. Although the experiment did not originally intend to distinguish high and low-running dams, an interesting observation is that neither CORT nor FLX significantly affected maternal care in lowrunning dams; future studies can attempt to characterize whether low intensity exercise is beneficial for maternal care or is not sufficient as an adjunct therapy to FLX.
Strenuous exercise could impair milk production (Treadway and Lederman, 1986) or alter milk nutrition content (Matsuno et al., 1999) in women, thereby impacting infant development. Although our study did not directly measure this, our findings indicate that exercise (regardless of high or low running) during gestation did not significantly affect size or sex ratio of birth litter. Furthermore, continuing to exercise after parturition did not affect pup growth by the time of weaning, suggesting that any effects of exercise on milk content were minimal. These observations are in line with similar findings that maternal exercise has little impact on infant growth in humans (Dewey et al., 1994; Su et al., 2007; Daley et al., 2012) , lactational competency (Prentice, 1994) or pup growth in rodents (Rosa et al., 2012) . Importantly, while exercise itself did not affect postnatal growth, it was not sufficient to prevent the negative effects of maternal postpartum CORT and FLX exposure on pup growth or maternal body mass. Therefore, although exercise itself may not necessitate concern during breastfeeding, its limited efficacy in metabolic measures of dams and offspring may be Table 5 Exercising dams maintained lower body mass from the beginning to end of pregnancy in comparison to no exercise. At the time of perfusion, CORT treatment reduced body mass in comparison to oil and reduced relative adrenal mass in dams. Under vehicle conditions, exercise increased adrenal mass in comparison to no exercise. Under no exercise/oil conditions, FLX increased adrenal mass in comparison to saline. Exercise had no significant effect on number of pups, ratio of male:female pups, or mass of the litter at the time of parturition. At the final week of the postpartum period, both maternal postpartum CORT as well as FLX independently reduced litter mass in comparison to oil and saline, respectively. Oil/Saline 267 ± 7 431 ± 7 344 ± 15 0.22 ± 0.02 15.3 ± 0.5 1.1 ± 0.1 107.9 ± 2.9 568 ± 13 Oil/FLX 329 ± 8 0.28 ± 0.02 501 ± 21 CORT/Saline 293 ± 10* 0.10 ± 0.01 504 ± 12 CORT/FLX 274 ± 8* 0.12 ± 0.01 423 ± 12
CORT: Corticosterone; FLX: Fluoxetine; G0: day 1 of pregnancy (conception); G21: day 21 of pregnancy. * denotes p < 0.05.
Table 6
Summary of the effects of maternal postpartum CORT on endophenotypes of postpartum depression and how FLX, exercise, and FLX þ exercise affected these measures under CORT-conditions. Maternal postpartum FLX prevented disruptions in maternal care and serum CORT recovery after FST1. Maternal exercise also prevented disruptions in maternal care and depression-like behavior in FST2. Further, FLX þ exercise or high running alone increased hippocampal neurogenesis in comparison to controls. important to note in cases of maternal depression or maternal use of FLX.
4.2. Postpartum CORT treatment impaired serum CORT recovery after stress and FLX treatment improved recovery in the CORTexposed dams
Maternal postpartum FLX facilitated serum CORT recovery after acute stress (FST1) in CORT-treated rats. Prior research suggests that antidepressant efficacy may be partly attributed to the ability of antidepressants to normalize HPA axis activity (Ising et al., 2007) . The postpartum is characterized by higher basal levels of CORT, attenuated HPA axis activation, and lower CORT-binding-globulin levels (i.e. increased free CORT), and these alterations may contribute to mood disturbances in mothers (Seth et al., 2016) . Although we previously found that FLX had no effect on CORT recovery 90 min after stress in CORT-treated dams, the means were in the predicted direction . In the present study maternal FLX improved CORT recovery 2 h after swim stress, which may be reflective of timing-or condition-specific effects. The present study measured serum CORT recovery after FST1 whereas the previous study ) measured CORT recovery after FST2 (the "test" session). Thus, it is possible that FLX facilitated CORT recovery in response to the initial acute stress exposure but not later after the second and shorter stress exposure. Importantly all dams had comparable stress-induced levels of serum CORT regardless of CORT treatment. Together with the stress recovery measure, this indicates that our dose of CORT increased and flattened HPA axis tone to a level relevant to postpartum female rat physiology, thus modelling hypercortsolemia and depression (Stetler and Miller, 2011) including PPD (Seth et al., 2016) .
Previous research demonstrated that exercise increases basal levels of glucocorticoids and adrenal gland mass, particularly the adrenal cortex (Droste et al., 2007) . Although the present study observed that exercise increased adrenal mass, exercise did not affect stress-induced or recovery serum CORT levels. However, it is possible that postpartum-induced glucocorticoid changes masked any exercise-induced changes in CORT and that exercise may have not been able to further stimulate HPA axis activity under the conditions of postpartum physiology. As expected, CORT treatment reduced relative adrenal mass as we have previously shown . This likely reflects exogenous CORT treatment suppressing HPA axis activity and subsequently endogenous CORT output.
4.3. Maternal exercise reduced depressive-like behavior whereas maternal postpartum FLX increased anxiety-like behavior and depressive-like behavior Exercise, regardless of CORT or FLX, reduced depressive-like behavior in FST2, consistent with previous findings in male and non-parturient female rodents (Lapmanee et al., 2013; Yau et al., 2014; Han et al., 2015) . Our findings are also consistent with clinical findings that exercise is efficacious for PPD (Armstrong and Edwards, 2003; Daley et al., 2015) . However, an element of social support also accompanied those clinical exercise interventions, obscuring the degree to which depression relief was attributable to exercise. Findings from the present study indeed point to the role of exercise itself in reducing maternal depressive-like behavior. Notably, another possible explanation is that exercise increased overall cardiovascular and muscular fitness or reduced adipose tissue, rendering exercise dams more adept than sedentary dams in active coping behavior in FST2. Although these factors have not been explicitly studied in forced swim test, voluntary running in rats is beneficial for cardiovascular and skeletal muscle health (P osa et al., 2015; Mobley et al., in press) which may ultimately contribute to forced swim test performance. However, using body mass as a covariate still resulted in the main effect of exercise to reduce immobility in the FLX. Indeed, voluntary running was substantially reduced during the postpartum, limiting the likelihood that robust cardiovascular fitness was involved. Moreover, if more running directly increased fitness, then it would then be reasonable to predict that high running dams would be the most fit. However, there were no significant effects of high or low running in the FST. These data collectively suggest that maternal exercise can reduce depressive-like behavior in this test.
Maternal FLX treatment increased both depressive-like behavior and anxiety-like behavior (which was partially explained by reduced food consumption), partially consistent with other studies (Mahmoud et al., 2016; Pawluski et al., 2012) . A lower dose of FLX also increased both anxiety-like and depressive-like behaviors in non-parous female rats (Mahmoud et al., 2016) . Similarly, prenatal stress followed by postpartum FLX treatment of rat dams increased anxiety-like behavior in the elevated zero maze (Pawluski et al., 2012) . Although SSRIs are prescribed to improve mood, few studies have tested whether antidepressants are efficacious in the postpartum, and of those conducted, the findings are inconclusive. Studies of antidepressant efficacy are limited by high attrition rates, differences in the baseline depression score, low sample size, and equal efficacy between SSRI and placebo treatment (Yonkers et al., 2008; Sharma and Sommerdyk, 2013; De Crescenzo et al., 2014; Hantsoo et al., 2014) . Research from preclinical models, including the present study, supports the limited efficacy of long-term SSRI treatment in dams , unless dams are continuously exposed to the SSRI via osmotic mini-pump (Haim et al., 2016) . Further, preclinical research has observed efficacy of FLX on maternal depressive-like behavior early in the postpartum on postpartum day 7 (Salari et al., 2016) . This is an interesting observation as the present study and previous work with this model found early beneficial effects of FLX on CORT-induced disruptions in maternal care (postpartum days 2e8). Thus, it is possible that SSRIs have a positive effect early in the postpartum but are ineffective with prolonged use, i.e. by the end of the postpartum period. Indeed, 57% of depressed patients who find antidepressant relief with SSRIs also relapse despite continual use of medication (Byrne and Rothschild, 1998) , and the trajectory of this cyclical relief and relapse with SSRI treatment may be different in mothers. It should also be noted that the effect of postpartum FLX treatment was apparent early in FST2 but not over the entire duration of FST2; however, this partially contradicts findings from Workman et al., 2016) , perhaps due to the additional stress (tail bleed) after FST1. PPD is a heterogenous disease with distinct symptom profiles depending on history of depression, timing of index episode, and presence of concurrent mood disorders (Postpartum Depression: Action Towards Causes and Treatment Consortium, 2015). An interesting avenue of future research would be to utilize rodent models to discern whether there are precise time windows and duration of exposure when SSRI intervention in a maternal depression model can yield positive effects on mood.
The combination of exercise and FLX treatment increased neurogenesis, and high running alone increased neurogenesis in ventral hippocampus
Maternal exercise, specifically high running, increased neurogenesis in the ventral dentate gyrus of dams, consistent with studies in male and non-parturient female rodents (van Praag et al., 1999; Yau et al., 2014) and confirming this exercise-induced neurogenic effect in the postpartum. Interestingly, this increase occurred specifically in the ventral dentate gyrus, which is functionally relevant for stress regulation (Fanselow and Dong, 2010) . However, others have observed that exercise predominantly increases neurogenesis in dorsal but not ventral hippocampus in male rodents (Tanti and Belzung, 2013; Vivar et al., 2016) , highlighting that exercise affects different sub-regions of the hippocampus during motherhood. The combinatory effect of exercise and FLX to increase neurogenesis was also observed to increase maternal behavior, particularly in high runners, and perhaps contributed to preventing CORT-induced disruptions in maternal care. Because neurogenesis levels are low during the postpartum due to increased circulating glucocorticoids (Leuner et al., 2007; Workman et al., 2016) , it is possible that a more potent manipulation such as high running was necessary to bolster neurogenesis. Furthermore, the difference in voluntary running activity between high runners and low runners in the present study was greatest during pre-conception and gestation. After parturition, all the dams engaged in similar levels of running wheel activity. This suggests that for high runners, activity earlier in the experiment was more influential on hippocampal plasticity, resulting in increased density of DCX-expressing cells by the end of the postpartum. It is noteworthy that DCX expression can last for three weeks (Brown et al., 2003) . Thus, while high running dams engaged in the most amount of running prior to parturition, high running likely had limited direct effects on DCX expression by the end of the postpartum period (approximately 3 weeks after parturition). However, running prior to parturition could have influenced DCX expression indirectly by the end of the postpartum period perhaps by increasing trophic factors that promoted generation of DCXexpressing cells. Further research could determine how running influenced the survival of cells generated prior to parturition in the postpartum hippocampus by using BrdU labelling; however, it should be noted that BrdU in the doses given to adult rats (200 mg/ kg) can have cytotoxic effects for the developing offspring which may influence developmental and maternal outcomes and thus was not used in the present study.
Interestingly, FLX increased neurogenesis only under exercise conditions while FLX reduced neurogenesis under sedentary conditions. This interaction is important for two reasons. First, under sedentary conditions, FLX decreased neurogenesis in addition to increasing depressive-like and anxiety-like behavior in dams. Collectively, these observations appear to be contrary to the expected antidepressant effects of FLX, but they underscore the gaps in our understanding how antidepressant interventions specifically in the postpartum affect the maternal brain and behavior. Indeed, studies examining effects of SSRIs on the maternal hippocampus observe either no significant effect on neurogenesis or a neurogenic effect when the SSRI is administered continuously via osmotic mini-pump (Pawluski et al., 2012) . As previously mentioned, there is limited evidence for postpartum antidepressant efficacy, and it would be reasonable to expect limited effects of SSRIs in the postpartum hippocampus. Secondly, exposure to both exercise and FLX increased neurogenesis in the postpartum hippocampus despite FLX reducing the amount of voluntary running in the postpartum. Thus, it is possible that the high running earlier in the experiment with its commensurate elevated neurogenesis is required for the neurogenic attributes of postpartum FLX. This may be due to increased serotonergic tone because exercise during pregnancy increased density of serotoninpositive cells in the dorsal raphe nucleus by the end of the postpartum (Seo et al., 2013) . Additional research is necessary to understand how interventions in pregnancy alter the postpartum brain. It is also plausible that within the normal conditions of postpartum physiology, including reduced neurogenesis and increased basal levels of glucocorticoids, a more robust regimen of antidepressants may be necessary to elicit changes in the postpartum hippocampus. Given the concerns regarding maternal SSRI exposure on child development, it may be of interest for further research in PPD treatments to consider a multimodal approach (i.e. a combination of pharmacological and non-pharmacological) as opposed to higher doses of SSRIs or other pharmacological antidepressants. Indeed, there is evidence that cell survival in the dorsal raphe nucleus (a major source of serotonergic innervation) is reduced in postpartum rat dams, an effect mediated by presence of pups (Holschbach and Lonstein, 2017) . Furthermore, (Banasr et al., 2001) showed that serotonin and estradiol interact to increase in cell proliferation in the dentate gyrus of adult female rats but more research should discern the dynamics between serotonin and hippocampal neurogenesis in the postpartum brain.
In conclusion, we show that exercise, but not FLX, can reduce maternal depressive-like behavior and that exercise coupled with FLX increased hippocampal neurogenesis. Further, FLX alone, or in combination with high running, prevented CORT-induced disruptions in maternal behavior. These independent and coordinated effects of an SSRI and exercise as antidepressants on CORT-induced endophenotypes of PPD highlight that maternal physiology is unique and underscore the importance of reproductive experience as a factor in translation of animal models of mood disorders. This study indicates that the postpartum affects efficacy of different types of interventions and contributes a better understanding of maternal mood disorders such as PPD.
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